rs26310

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001001331.4(ATP2B2):​c.3421-2031A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.392 in 152,098 control chromosomes in the GnomAD database, including 12,282 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.39 ( 12282 hom., cov: 33)

Consequence

ATP2B2
NM_001001331.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.507

Publications

5 publications found
Variant links:
Genes affected
ATP2B2 (HGNC:815): (ATPase plasma membrane Ca2+ transporting 2) The protein encoded by this gene belongs to the family of P-type primary ion transport ATPases characterized by the formation of an aspartyl phosphate intermediate during the reaction cycle. These enzymes remove bivalent calcium ions from eukaryotic cells against very large concentration gradients and play a critical role in intracellular calcium homeostasis. The mammalian plasma membrane calcium ATPase isoforms are encoded by at least four separate genes and the diversity of these enzymes is further increased by alternative splicing of transcripts. The expression of different isoforms and splice variants is regulated in a developmental, tissue- and cell type-specific manner, suggesting that these pumps are functionally adapted to the physiological needs of particular cells and tissues. This gene encodes the plasma membrane calcium ATPase isoform 2. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
ATP2B2 Gene-Disease associations (from GenCC):
  • hearing loss, autosomal dominant 82
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • autosomal recessive nonsyndromic hearing loss 12
    Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia
  • neurodevelopmental disorder
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.555 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ATP2B2NM_001001331.4 linkc.3421-2031A>G intron_variant Intron 22 of 22 ENST00000360273.7 NP_001001331.1 Q01814-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ATP2B2ENST00000360273.7 linkc.3421-2031A>G intron_variant Intron 22 of 22 5 NM_001001331.4 ENSP00000353414.2 Q01814-1

Frequencies

GnomAD3 genomes
AF:
0.392
AC:
59599
AN:
151980
Hom.:
12275
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.468
Gnomad AMI
AF:
0.316
Gnomad AMR
AF:
0.446
Gnomad ASJ
AF:
0.340
Gnomad EAS
AF:
0.572
Gnomad SAS
AF:
0.418
Gnomad FIN
AF:
0.329
Gnomad MID
AF:
0.364
Gnomad NFE
AF:
0.333
Gnomad OTH
AF:
0.368
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.392
AC:
59648
AN:
152098
Hom.:
12282
Cov.:
33
AF XY:
0.395
AC XY:
29396
AN XY:
74364
show subpopulations
African (AFR)
AF:
0.467
AC:
19382
AN:
41462
American (AMR)
AF:
0.446
AC:
6816
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.340
AC:
1180
AN:
3466
East Asian (EAS)
AF:
0.572
AC:
2957
AN:
5168
South Asian (SAS)
AF:
0.419
AC:
2024
AN:
4828
European-Finnish (FIN)
AF:
0.329
AC:
3486
AN:
10598
Middle Eastern (MID)
AF:
0.361
AC:
106
AN:
294
European-Non Finnish (NFE)
AF:
0.333
AC:
22623
AN:
67970
Other (OTH)
AF:
0.371
AC:
786
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1843
3685
5528
7370
9213
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
572
1144
1716
2288
2860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.352
Hom.:
16261
Bravo
AF:
0.405
Asia WGS
AF:
0.503
AC:
1756
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
2.5
DANN
Benign
0.45
PhyloP100
0.51
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs26310; hg19: chr3-10372840; API